Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

antibiotice - piperacillinnatrium, tazobactamnatrium - pulver til infusionsvæske, opløsning - 2+0,25 g

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

antibiotice - piperacillinnatrium, tazobactamnatrium - pulver til infusionsvæske, opløsning - 4+0,5 g

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxo group ltd - retapamulins - impetigo; staphylococcal skin infections - antibiotika og kemoterapeutiske midler til dermatologisk brug - short term treatment of the following superficial skin infections: , impetigo;, infected small lacerations, abrasions or sutured wounds. se afsnit 4. 4 og 5. 1 for vigtige oplysninger om den kliniske aktivitet af retapamulin mod forskellige typer af staphylococcus aureus. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibakterielle midler til systemisk brug, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler.. hensigtsmæssig brug af antibakterielle midler..

Den Europæiske Union - dansk - EMA (European Medicines Agency)

instituto grifols s.a. - humant normalt immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immune sera og immunoglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

antibiotice s.a. - meropenem (trihydrat) - pulver til injektions-/infusionsvæske, opløsning - 1 g

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

antibiotice - ampicillinnatrium - pulver til injektions-/infusionsvæske, opløsning - 1 g

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

antibiotice - ampicillinnatrium - pulver til injektions-/infusionsvæske, opløsning - 2 g

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

antibiotice - ampicillinnatrium - pulver til injektions-/infusionsvæske, opløsning - 500 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

antibiotice - lisinoprildihydrat - tabletter - 10 mg